EPO Patents = 2

Trademarks = 2

Forward Citations = 1

Loading Chart...

6 inventors (with patents filed for the assignee):

Marko Poglitsch (5 out of 5 patents)

Cornelia Schwager (5 out of 5 patents)

Hans Loibner (3 out of 32 patents)

4. Dunja Van Oyen (2 out of 2 patents)

5. Martin Leitner (2 out of 2 patents)

6. Manfred Schuster (2 out of 17 patents)

5 patents: Sort by Forward Citations

1. 11079398 - Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples (2021-08-03),

2. 10295552 - Method for diagnosis of primary hyperaldosteronism (2019-05-21),

3. 9839668 - Compositions and methods for the treatment of diseases related to the renin-angiotensin-system (2017-12-12),

4. 9829496 - Method for diagnosis of primary hyperaldosteronism (2017-11-28),

5. 9684004 - Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples (2017-06-20),

Attoquant Diagnostics GmbH is a biotechnology company specializing in developing innovative diagnostic solutions for precision medicine. Their cutting-edge technology allows for highly sensitive and specific detection of biomarkers, enabling early diagnosis and personalized treatment for various diseases.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#112 in Vienna

#515 in Austria

Vienna, Austria

Attoquant Diagnostics Gmbh